Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Synthesis

Contraceptive Correction

April 20, 2009 | A version of this story appeared in Volume 87, Issue 16

IN HIS EDITORIAL reviewing the history of oral contraceptives, Rudy Baum inaccurately states that norethindrone was the basis for the first such product (C&EN, Sept. 22, 2008, page 5).

Norethynodrel, not norethindrone, was the basis for the first oral contraceptive. The former substance, together with a small amount of mestranol, was marketed in 1960 by G. D. Searle & Co. under the trade name Enovid. The product based on norethindrone, also containing a small amount of mestranol, was not marketed until three years later, in 1963, by the Ortho Division of Johnson & Johnson under the trade name Ortho Novum.

Raphael Pappo
Elliot Schubert
San Diego

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.